GERMANTOWN, Md., Aug. 13, 2013 /PRNewswire/ -- Intrexon Corporation (NYSE: XON) today announced the closing of its previously announced initial public offering of common stock. The total number of shares sold was 11,499,998, composed of 9,999,999 shares initially offered and an additional 1,499,999 shares sold pursuant to the full exercise of the underwriters' over-allotment option, in each case at an initial public offering price of $16.00 per share. All of the common stock was sold by Intrexon.
J.P. Morgan and Barclays acted as joint book-running managers for the offering. Griffin Securities and Mizuho Securities acted as co-managers.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on August 7, 2013. A copy of the final prospectus relating to this offering may be obtained by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone at (866) 803-9204 or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (888) 603-5847 or by e-mail at Barclaysprospectus@broadridge.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is a biotechnology company focused on collaborating with companies in Health, Food, Energy, and the Environment to create biologically based products that improve the quality of life and health of the planet.
SOURCE Intrexon Corporation